These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 20931982)
1. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982 [TBL] [Abstract][Full Text] [Related]
2. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry. Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412 [TBL] [Abstract][Full Text] [Related]
3. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278 [TBL] [Abstract][Full Text] [Related]
4. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. Liu T; Qian WJ; Gritsenko MA; Camp DG; Monroe ME; Moore RJ; Smith RD J Proteome Res; 2005; 4(6):2070-80. PubMed ID: 16335952 [TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers analyzed by LC-MS/MS as predictors for short outcome of non-small cell lung cancer patients treated with chemoradiotherapy. Huang W; Ding X; Li B; Fan M; Zhou T; Sun H; Yi Y; Zhang J Neoplasma; 2013; 60(1):11-8. PubMed ID: 23067211 [TBL] [Abstract][Full Text] [Related]
6. Large-scale Identification of N-linked Intact Glycopeptides in Human Serum using HILIC Enrichment and Spectral Library Search. Shu Q; Li M; Shu L; An Z; Wang J; Lv H; Yang M; Cai T; Hu T; Fu Y; Yang F Mol Cell Proteomics; 2020 Apr; 19(4):672-689. PubMed ID: 32102970 [TBL] [Abstract][Full Text] [Related]
7. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Chen R; Tan Y; Wang M; Wang F; Yao Z; Dong L; Ye M; Wang H; Zou H Mol Cell Proteomics; 2011 Jul; 10(7):M110.006445. PubMed ID: 21474793 [TBL] [Abstract][Full Text] [Related]
8. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma. Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909 [TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography. Song E; Zhu R; Hammoud ZT; Mechref Y J Proteome Res; 2014 Nov; 13(11):4808-20. PubMed ID: 25134008 [TBL] [Abstract][Full Text] [Related]
10. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry. Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727 [TBL] [Abstract][Full Text] [Related]
11. Highly efficient enrichment method for human plasma glycoproteome analyses using tandem hydrophilic interaction liquid chromatography workflow. Jie J; Liu D; Yang B; Zou X J Chromatogr A; 2020 Jan; 1610():460546. PubMed ID: 31570191 [TBL] [Abstract][Full Text] [Related]
12. Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery. Drake P; Schilling B; Gibson B; Fisher S Methods Mol Biol; 2013; 951():307-22. PubMed ID: 23296540 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. Whelan SA; Lu M; He J; Yan W; Saxton RE; Faull KF; Whitelegge JP; Chang HR J Proteome Res; 2009 Aug; 8(8):4151-60. PubMed ID: 19522481 [TBL] [Abstract][Full Text] [Related]
15. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS. Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881 [TBL] [Abstract][Full Text] [Related]
16. Development of an online microbore hollow fiber enzyme reactor coupled with nanoflow liquid chromatography-tandem mass spectrometry for global proteomics. Kim JY; Lee SY; Kim SK; Park SR; Kang D; Moon MH Anal Chem; 2013 Jun; 85(11):5506-13. PubMed ID: 23634719 [TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic Alterations in Drug-Resistant Nonsmall Cell Lung Cancer Cells Revealed by Lectin Magnetic Nanoprobe-Based Mass Spectrometry. Waniwan JT; Chen YJ; Capangpangan R; Weng SH; Chen YJ J Proteome Res; 2018 Nov; 17(11):3761-3773. PubMed ID: 30261726 [TBL] [Abstract][Full Text] [Related]
18. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker. Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422 [TBL] [Abstract][Full Text] [Related]
19. [Large-scale enrichment and identification of human urinary Shang S; Dong H; Li Y; Zhang W; Li H; Qin W; Qian X Se Pu; 2021 Jul; 39(7):686-694. PubMed ID: 34227365 [TBL] [Abstract][Full Text] [Related]
20. Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and liquid chromatography/electrospray ionization tandem mass spectrometry. Xu Y; Bailey UM; Punyadeera C; Schulz BL Rapid Commun Mass Spectrom; 2014 Mar; 28(5):471-82. PubMed ID: 24497285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]